Randomized Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stents vs. Sirolimus-Eluting Stents for Percutaneous Coronary Intervention in Chronic Total Occlusion
Hun‐Jun Park(Soonchunhyang University), Ki‐Bae Seung, Kiyuk Chang(St. Mary's Hospital), Yoon Seok Choi(Ajou University Hospital), Dong‐Bin Kim(St. Paul's Hospital), Sung‐Ho Her(St. Mary's Hospital), Jong Min Lee(Dongguk University), Chul‐Soo Park(Catholic University of Korea), Mahn Won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Yoon Seok Koh(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Wook Sung Chung(The Catholic University of Korea Seoul St. Mary's Hospital), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Pum Joon Kim(St. Paul's Hospital), Beom‐June Kwon(Catholic University of Korea)
Cited by 46
Related Papers
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493